Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges.

Front Cell Dev Biol · 2025 · PMC11830822 · PMID 39963155

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

This suggests that there may be significant differences in the mechanisms underlying the effects of MSCs in RRMS and progressive MS.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.